Bayer Cropscience Ltd
NSE:BAYERCROP
Intrinsic Value
Bayer CropScience Ltd. engages in the manufacture, sale, and distribution of crop protection products. [ Read More ]
The intrinsic value of one
BAYERCROP
stock under the Base Case scenario is
4 169.16
INR.
Compared to the current market price of 5 717.65 INR,
Bayer Cropscience Ltd
is
Overvalued by 27%.
BAYERCROP's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
BAYERCROP or that its price is influenced by factors unrelated to fundamentals.
Bayer Cropscience Ltd's market capitalization is 257B INR.
BAYERCROP stock price is 5 717.65 INR.
BAYERCROP stock (4 169.16 INR) is 27% less than its price (5717.65 INR).
BAYERCROP stock (2 513.75 INR) is 56% less than its price (5717.65 INR). Open DCF Valuation
BAYERCROP stock price (5717.65 INR) is 2% less than its Relative Value (5 824.58 INR). Open Relative Valuation
BAYERCROP has upside potential of 8% compared to the average analyst price target.
Open Wall St Estimates
BAYERCROP's ROE (Return on Equity) has increased in the last 3 years from 19% to 21%.
BAYERCROP's Revenue has been growing by 3% per year for the last 3 years.
BAYERCROP has positive Net Income for the last twelve months.
BAYERCROP's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 15%.
BAYERCROP's ROIC (Return on Invested Capital) has decreased in the last 3 years from 21% to 15%.
BAYERCROP's Revenue is forecast to grow at a rate of 9% per year over the next 3 years.
BAYERCROP has positive Operating Income for the last twelve months.
BAYERCROP's ROE (Return on Equity) for the past 12 months is positive and is equal to 21%.
BAYERCROP's Revenue has dropped by 16% over the past 12 months.
BAYERCROP has negative Free Cash Flow for the last twelve months.
BAYERCROP has positive three-year average ROIC (Return on Invested Capital): 19%. The company is efficient at using invested capital to generate operating income.
BAYERCROP has positive three-year average ROE (Return on Equity): 22%. The company is efficient at transforming stockholders' equity into net income.
BAYERCROP has positive Gross Profit for the last twelve months.
BAYERCROP's short-term assets (45B INR) exceed its short-term liabilties (19B INR).
BAYERCROP's long-term assets (52B INR) exceed its long-term liabilties (21B INR).
BAYERCROP's D/E (Debt to Equity) is very low and is equal to 0.01.
BAYERCROP has negative Net Debt. This means that the company has more cash and short-term investments (1B INR) than debt (169m INR).
BAYERCROP's Altman Z-Score is very high and is equal to 9.91.
BAYERCROP earns more than enough operating income (8B INR) to safely cover interest payments on its debt (12m INR).
Valuation Backtest
Bayer Cropscience Ltd
Run backtest to discover the historical profit from buying and selling
BAYERCROP
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Bayer Cropscience Ltd
Balance Sheet Decomposition
Bayer Cropscience Ltd
| Current Assets | 44.5B |
| Cash & Short-Term Investments | 1B |
| Receivables | 19.9B |
| Other Current Assets | 23.6B |
| Non-Current Assets | 7.6B |
| Long-Term Investments | 340m |
| PP&E | 4.1B |
| Intangibles | 1.2B |
| Other Non-Current Assets | 2.1B |
| Current Liabilities | 19.4B |
| Accounts Payable | 6B |
| Other Current Liabilities | 13.5B |
| Non-Current Liabilities | 1.4B |
| Long-Term Debt | 169m |
| Other Non-Current Liabilities | 1.2B |
Earnings Waterfall
Bayer Cropscience Ltd
|
Revenue
|
43.1B
INR
|
|
Cost of Revenue
|
-25.3B
INR
|
|
Gross Profit
|
17.8B
INR
|
|
Operating Expenses
|
-9.8B
INR
|
|
Operating Income
|
8B
INR
|
|
Other Expenses
|
-1.5B
INR
|
|
Net Income
|
6.4B
INR
|
Free Cash Flow Analysis
Bayer Cropscience Ltd
BAYERCROP Profitability Score
Profitability Due Diligence
Bayer Cropscience Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Bayer Cropscience Ltd's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
BAYERCROP Solvency Score
Solvency Due Diligence
Bayer Cropscience Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Score
Bayer Cropscience Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BAYERCROP Price Targets Summary
Bayer Cropscience Ltd
According to Wall Street analysts, the average 1-year price target for
BAYERCROP
is 6 186.41 INR
with a low forecast of 5 050 INR and a high forecast of 7 545.3 INR.
Shareholder Return
BAYERCROP Price
Bayer Cropscience Ltd
| Average Annual Return | 9.45% |
| Standard Deviation of Annual Returns | 29.69% |
| Max Drawdown | -26% |
| Market Capitalization | 256.4B INR |
| Shares Outstanding | 44 942 100 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Bayer Cropscience Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Bayer CropScience Ltd. engages in the manufacture, sale, and distribution of crop protection products. The company is headquartered in Thane, Maharashtra and currently employs 1,318 full-time employees. The company went IPO on 2010-01-08. The firm operates through Agri Care segment. The company offers crop solutions for various crops, such as cotton, fruits, millet, mustard, pulses, rice, soybeans, sugar cane, vegetables and wheat. The firm offers various pest management solutions, such as Professional Pest Management for household / structural pests and Vector Management for pests that pose a threat to public health. The company offers various brands, such as Aliette, Antracol, Folicur, Melody Duo and Nativo under the fungicides category; Adora, Atlantis, Laudis, Lucifer, Raft, Ricestar and Topstar under the herbicides category; Admire, Alanto, Confidor, Decis 100, Fame, Flotis, Jump, Larvin and Spintor under the insecticides category; Emesto Prime, Gaucho and Raxil Easy under the SeedGrowth category, and Ethrel and Planofix under the others category.
Contact
IPO
Employees
Officers
The intrinsic value of one
BAYERCROP
stock under the Base Case scenario is
4 169.16
INR.
Compared to the current market price of 5 717.65 INR,
Bayer Cropscience Ltd
is
Overvalued by 27%.
You don't have any saved screeners yet
